Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.

The Journal of pediatrics - 1 May 2015

Miller Melissa R, Soave David, Li Weili, Gong Jiafen, Pace Rhonda G, Boëlle Pierre-Yves, Cutting Garry R, Drumm Mitchell L, Knowles Michael R, Sun Lei, Rommens Johanna M, Accurso Frank, Durie Peter R, Corvol Harriet, Levy Hara, Sontag Marci K, Strug Lisa J

Abstract excerpt

OBJECTIVES: To test the hypothesis that multiple constituents of the apical plasma membrane residing alongside the causal cystic fibrosis (CF) transmembrane conductance regulator protein, including known CF modifiers SLC26A9, SLC6A14, and SLC9A3, would be associated with prenatal exocrine pancreatic damage as measured by newborn screened (NBS) immunoreactive trypsinogen (IRT) levels. STUDY DESIGN: NBS IRT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiporters
Share to Colorado

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to Neonatal Screening

Share to Quality Control

Share to Sulfate Transporters

Share to Trypsinogen

Share to Wisconsin

Source

Open in PubMed Open full text

Identifiers

PMID: 25771386
DOI: 10.1016/j.jpeds.2015.01.044
PMCID: PMC4530786

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.PMID 25771386Read ↗

Susceptibility haplotypes in non-cystic fibrosis newborns with elevated immunoreactive trypsinogenSemantic proximity Read ↗

Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study.Semantic proximity Read ↗

Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis.Semantic proximity Read ↗

Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.Semantic proximity Read ↗

The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.Semantic proximity Read ↗

Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birthSemantic proximity Read ↗

The Solute Carrier Family 26 Member 9 Is a Modifier of the Rapidly Progressing Cystic Fibrosis Associated with F508del CFTR MutationsSemantic proximity Read ↗

Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.Semantic proximity Read ↗

Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.Semantic proximity Read ↗

Increase in Sweat Chloride Concentration Is Associated with a Higher Risk of CFSPID to CF ReclassificationSemantic proximity Read ↗

Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review.Semantic proximity Read ↗

The solute carrier family 26 member 9 modifies rapidly progressing cystic fibrosis associated with homozygous F508del CFTR mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.